Bleomycin
| Generic name | Bleomycin |
| Pronunciation | blee-oh-MY-sin |
| Brand name(s), other common name(s) | Blenoxane® |
| Drug type | Antitumor antibiotic |
| How the drug is given | Intravenously (IV) or by intramuscular (IM) or subcutaneous (SC) injection |
Bleomycin is FDA approved as a single agent or in proven combinations to treat people who have Hodgkin and non-Hodgkin lymphoma. Bleomycin may cause a temporary loss of hair in some people. Normal hair growth should return after treatment ends (although it may take several months).
Side effects needing medical attention:
Cough; shortness of breath.
For information on how to manage the costs of drug therapy, please see Financial Matters and Prescription Drug Coverage, or to speak with an Information Specialist, call (800) 955-4572.
